Hemophilia: Understanding Inhibitors

Patients with hemophilia (a blood clotting disorder) can develop inhibitors (also called antibodies) when they have an immune response to factor concentrates (the treatment for hemophilia). Treatment of inhibitors is one of the biggest challenges in hemophilia care because patients with inhibitors can face greater risk of bleeding and the technique to get rid of inhibitors requires specialized medical expertise, is expensive, and can take a long time. Read below for more information about the development, diagnosis, and treatment of hemophilia with inhibitors.

This tear sheet was produced in collaboration with the World Federation of Hemophilia (wfh.org).

Patient Education: Hemophilia: Understanding Inhibitors